Investigation of the safety and utility of topical treatment with glycyrrhetinic acid / CMC-Na ointment for oral lichen planus

chida Fumihiko0 个研究点目标入组 10 人开始时间: 2022年8月31日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with first-episode oral lichen planus whose pathological diagnosis of oral lichen planus was confirmed by biopsy
•2) Steroid-naive patients with oral lichen planus
•3) Patients with complaints of pain due to oral lichen planus (Numerical Rating Scale; NRS 1 or more)
•4) Patients who are at least 18 years of age at the time of consent
•5) Patients who have been fully informed, understand, and give written consent to participate in this study
•6) Outpatients

•1) Patients with severe pain due to oral lichen planus (mean NRS 7 or more)
•2)Patients with hypersensitivity to the study drug
•3) Pregnant patients
•4) Patients with active malignancy
•5) Patients who are using or will use biologic agents during the study period
•6) Patients who are using or will use immunosuppressive drugs during this study
•7) Patients receiving steroid therapy for diseases other than lichen planus of the oral cavity
•8) Patients with suspected acute abdomen
•9) Patients with severe hard stools

发起方

chida Fumihiko